HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$4.74
Day range
$4.63 - $4.91
Year range
$3.90 - $14.67
Market cap
336.25M USD
Avg Volume
698.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.72M | 12.86% |
Net income | -30.02M | -20.03% |
Net profit margin | — | — |
Earnings per share | -0.42 | -13.51% |
EBITDA | -32.42M | -12.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.72M | -35.69% |
Total assets | 242.86M | -30.77% |
Total liabilities | 23.12M | 4.42% |
Total equity | 219.74M | — |
Shares outstanding | 71.09M | — |
Price to book | 1.53 | — |
Return on assets | -31.64% | — |
Return on capital | -34.01% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.02M | -20.03% |
Cash from operations | -32.53M | -7.78% |
Cash from investing | 22.45M | 136.29% |
Cash from financing | 11.00K | -99.99% |
Net change in cash | -10.07M | -130.54% |
Free cash flow | -22.66M | -6.46% |
About
Founded
2014
Headquarters
Website
Employees
122
